10Aug 2018

ANTHROPOMETRIC MEASUREMENTS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME IN SAUDI ARABIA.

Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: Polycystic Ovary Syndrome is a common endocrine disorder that is characterized by the presence of chronic anovulation, excess levels of androgen as well as polycystic ovary on ultrasonographic imaging. Objectives: To determine the causes, complications and clinical features of polycystic ovary syndrome. To assess the anthropometric measurements of obesity in polycystic ovary syndrome Saudi women and to provide treatment for the associated obesity. Review of Literature: Polycystic Ovary Syndrome involves interactions between different components such as the anterior pituitary gland, hypothalamus, ovaries, suprarenal glands and peripheral fatty tissues. It seems to be a multifactorial disease. It presents with different manifestations and it can affect the metabolic and reproductive functions as well as the cardiovascular system. Abdominal obesity can initiate the pathogenesis of Polycystic Ovary Syndrome and the opposite is true. Clinical features, laboratory tests and ultrasound imaging are the clinical diagnosis. There is a high incidence rate within Saudi population due to increasing obesity. It has a significant effect on anthropometric body profiles of Saudi women. However, lifestyle modifications and pharmacological therapies have an essential role in management of obesity related to this syndrome. Conclusion: The etiology of Polycystic Ovary Syndrome is multifactorial and is linked to long term complications that present with cardinal features. It is significantly associated with high anthropometric findings in Saudi Arabian women, but lifestyle interventions and pharmacotherapy are effective in losing weight.

  1. Franks S. Polycystic ovary syndrome. Medicine. 2017;45(9):527-531.
  2. Carmina E. Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women. Journal of Clinical Endocrinology & Metabolism. 1999;84(6):1897-1899.
  3. Guraya S. Prevalence and ultrasound features of polycystic ovaries in young unmarried Saudi females. Journal of Microscopy and Ultrastructure. 2013;1(1):30.
  4. Johansson J, Stener-Victorin E. Polycystic Ovary Syndrome: Effect and Mechanisms of Acupuncture for Ovulation Induction. Evidence-Based Complementary and Alternative Medicine. 2013;2013:1-16.
  5. Aubuchon M, Bickhaus J, Gonz?lez F. Obesity, Metabolic Dysfunction, and Inflammation in Polycystic Ovary Syndrome. Polycystic Ovary Syndrome. 2013;:117-144.
  6. Di-Fei Lu X. Parameters of obesity in polycystic ovary syndrome [Internet]. Rarediseasesjournal.com. 2018 [cited 18 March 2018]. Available from: http://www.rarediseasesjournal.com/articles/Parameters-of-obesity-in-polycystic-ovary-syndrome-raredis-1-1078.php.
  7. M Alqarni S. A Review of Prevalence of Obesity in Saudi Arabia. Journal of Obesity & Eating Disorders. 2016;02(02).
  8. Barber T, Dimitriadis G, Franks S. Polycystic Ovary Syndrome and Obesity. Obesity. 2016;:199-210.
  9. Porcaro G G. Polycystic Ovary Syndrome: Features, Diagnostic Criteria and Treatments. Endocrinology & Metabolic Syndrome. 2014;03(03).
  10. Pelusi C, Pasquali R. Polycystic Ovary Syndrome in Adolescents. Treatments in Endocrinology. 2003;2(4):215-230.
  11. Rojas J, Ch?vez M, Olivar L, Rojas M, Morillo J, Mej?as J et al. Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth. International Journal of Reproductive Medicine. 2014;2014:1-17.
  12. Dumitrescu D. The Polycystic Ovary Syndrome: An update on metabolicand hormonal mechanisms [Internet]. PubMed Central (PMC). 2018 [cited 18 March 2018]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392092/.
  13. Freeman R. The Role of the Adrenal Glands in the Hyperandrogenism Associated with Polycystic Ovarian Syndrome. Polycystic Ovary Syndrome. 2013;:71-80.
  14. Chang W, Azziz R. Pathogenesis of Hyperandrogenism in Polycystic Ovary Syndrome. Contemporary Endocrinology. :281-294.
  15. De Leo V, Musacchio M, Cappelli V, Massaro M, Morgante G, Petraglia F. Genetic, hormonal and metabolic aspects of PCOS: an update. Reproductive Biology and Endocrinology. 2016;14(1).
  16. Franks S, Berga S. Does PCOS have developmental origins?. Fertility and Sterility. 2012;97(1):2-6.
  17. Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y. Vitamin D Is an Important Factor in Estrogen Biosynthesis of Both Female and Male Gonads1. Endocrinology. 2000;141(4):1317-1324.
  18. Alsibyani N, Malibary M, Derham A. Clinical Presentation of Polycystic Ovary Syndrome among Saudi Arabian Women - Jeddah, Saudi Arabia. The Egyptian Journal of Hospital Medicine. 2017;67(1):494-498.
  19. Stracquadanio M, Ciotta L. Clinical Features. Metabolic Aspects of PCOS. 2015;:21-62.
  20. Lenzy Y, Batts A. Androgenetic Alopecia. Clinical Cases in Skin of Color. 2015;:41-50.
  21. Wellons M, Rebar R. Amenorrhea. Clinical Reproductive Medicine and Surgery. 2013;:105-112.
  22. Homburg R, Crawford G. The role of AMH in anovulation associated with PCOS: a hypothesis. Human Reproduction. 2014;29(6):1117-1121.
  23. Sheehan M. Polycystic Ovarian Syndrome: Diagnosis and Management [Internet]. NCBI. 2004 [cited 18 March 2018]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1069067/
  24. Lee T, Rausch M. Polycystic Ovarian Syndrome: Role of Imaging in Diagnosis. RadioGraphics. 2012;32(6):1643-1657.
  25. Johnston-MacAnanny E, Berga S. Polycystic Ovary Syndrome. Clinical Reproductive Medicine and Surgery. 2017;:123-137.
  26. Carreau A, Baillargeon J. PCOS in Adolescence and Type 2 Diabetes. Current Diabetes Reports. 2014;15(1).
  27. Sood M, Zweig S, Tolentino M, Strizhevsky M, Poretsky L. Polycystic Ovary Syndrome. Principles of Diabetes Mellitus. 2017;:659-677.
  28. Nandi A, Chen Z, Patel R, Poretsky L. Polycystic Ovary Syndrome. Endocrinology and Metabolism Clinics of North America. 2014;43(1):123-147.
  29. Behboudi-Gandevani S, Ramezani Tehrani F, Bidhendi Yarandi R, Noroozzadeh M, Hedayati M, Azizi F. The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines. Journal of Endocrinological Investigation. 2017;40(8):859-866.
  30. Kim J, Choi Y. Dyslipidemia in women with polycystic ovary syndrome. Obstetrics & Gynecology Science. 2013;56(3):137.
  31. Scicchitano P, Dentamaro I, Carbonara R, Bulzis G, Dachille A, Caputo P et al. Cardiovascular Risk in Women With PCOS [Internet]. NCBI. 2012 [cited 18 March 2018]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693634/
  32. Randeva H, Tan B, Weickert M, Lois K, Nestler J, Sattar N et al. Cardiometabolic Aspects of the Polycystic Ovary Syndrome. Endocrine Reviews. 2012;33(5):812-841.
  33. Ali A. Reproductive Factors and the Risk of Endometrial Cancer. International Journal of Gynecological Cancer. 2014;24(3):384-393.
  34. Panidis D, Tziomalos K, Papadakis E, Vosnakis C, Chatzis P, Katsikis I. Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility. Endocrine. 2013;44(3):583-590.
  35. Azziz R, Carmina E, Chen Z, Dunaif A, Laven J, Legro R et al. Polycystic ovary syndrome. Nature Reviews Disease Primers. 2016;2:16057.
  36. Escobar-Morreale H, Mill?n J. Abdominal adiposity and the polycystic ovary syndrome. Trends in Endocrinology & Metabolism. 2007;18(7):266-272.
  37. Delitala A, Capobianco G, Delitala G, Cherchi P, Dessole S. Polycystic ovary syndrome, adipose tissue and metabolic syndrome. Archives of Gynecology and Obstetrics. 2017;296(3):405-419.
  38. Hong L, Zhang Y, Wang Q, Han Y, Teng X. Effects of interleukin 6 and tumor necrosis factor-α on the proliferation of porcine theca interna cells: Possible role of these cytokines in the pathogenesis of polycystic ovary syndrome. Taiwanese Journal of Obstetrics and Gynecology. 2016;55(2):183-187.
  39. Lim S, Davies M, Norman R, Moran L. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update. 2012;18(6):618-637.
  40. WANG J, THORNTON J, KOLESNIK S, PIERSON R. Anthropometry in Body Composition: An Overview. Annals of the New York Academy of Sciences. 2006;904(1):317-326.
  41. Pasco J, Holloway K, Dobbins A, Kotowicz M, Williams L, Brennan S. Body mass index and measures of body fat for defining obesity and underweight: a cross-sectional, population-based study. BMC Obesity. 2014;1(1).
  42. Tamimi W, Siddiqui I, Tamim H, AlEisa N, Adham M. Effect of body mass index on clinical manifestations in patients with polycystic ovary syndrome. International Journal of Gynecology & Obstetrics. 2009;107(1):54-57.
  43. Al-Mulhim A, Abul-Heija A, Al-Talib A, Al-Turki H, Gasim T. Hormonal, metabolic and clinical profile of Saudi women with polycystic ovary syndrome. Saudi Journal of Medicine and Medical Sciences. 2013;1(1):30.
  44. AL-Nozha O, Habib F, Mojaddidi M, El-Bab M. Body weight reduction and metformin: Roles in polycystic ovary syndrome. Pathophysiology. 2013;20(2):131-137.
  45. Organization W. Waist circumference and waist-hip ratio : report of a WHO expert consultation, Geneva, 8-11 December 2008 [Internet]. Who.int. 2018 [cited 19 March 2018]. Available from: http://www.who.int/iris/handle/10665/44583
  46. Daghestani M, Daghestani M, El-Mazny A. Circulating ghrelin levels and the polycystic ovary syndrome: correlation with the clinical, hormonal and metabolic features. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2011;155(1):65-68.

[Rahaf Adel Saleh Afandi. (2018); ANTHROPOMETRIC MEASUREMENTS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME IN SAUDI ARABIA. Int. J. of Adv. Res. 6 (Aug). 407-416] (ISSN 2320-5407). www.journalijar.com

Rahaf Adel Saleh Afandi
College of Medicine, Taibah University

DOI:

Article DOI: 10.21474/IJAR01/7535      
DOI URL: https://dx.doi.org/10.21474/IJAR01/7535

Download Full Paper

Download PDF No. of Downloads: 65 | No. of Views: 190